Amyris to pay cannabinoid manufacturer Lavvan $15.1 million in settlement
Biotech company Amyris will pay its former business partner, cannabinoid manufacturer Lavvan, $15.1 million as part of a settlement agreement that ends years of litigation.
California Medical Marijuana News
Biotech company Amyris will pay its former business partner, cannabinoid manufacturer Lavvan, $15.1 million as part of a settlement agreement that ends years of litigation.
Intoxicating cannabis is being sold in accordance with state laws. But it’s not sold as marijuana – it’s labeled THCA, which is psychoactive when heated.
R&D cannabis lines – or limited-edition, small-batch flower – can create a line of communication between cultivators and consumers, enabling marijuana operators to conduct market research while still bringing in revenue.
Planet 13 Holdings has recovered $3.4 million from its case against an investment firm that the marijuana multistate operator alleges “embezzled money from the company’s accounts,” co-CEO Robert Groesbeck told investors.
California-based Jean Talley sat down with MJBizDaily to share his perspective about medical cannabis research.
Voters in Humboldt County, California, soundly rejected a ballot initiative Tuesday that aimed to widely curb marijuana cultivation in that region.
MedMen Enterprises has shuttered all but two of its stores in California, workers confirmed to MJBizDaily. Only MedMen stores in San Diego and near Los Angeles International Airport remain open.